WHA69.20 - Promoting Innovation and Access to Quality, Safe, Efficacious and Affordable Medicines for Children. WHA Resolution; Sixty-ninth World Health Assembly, 2016
(2016; 4 pages) [Arabic] [Chinese] [French] [Russian] [Spanish]

Abstract

REQUESTS the Director-General:

  1. to accelerate implementation of the actions laid out in resolutions WHA60.20 on better medicines for children, WHA67.22 on access to essential medicines and WHA67.20 on regulatory system strengthening for medical products;
  2. to further develop and maintain, within the Model List of Essential Medicines, the Model List of Essential Medicines for Children, using evidence-based clinical guidelines in coordination with all relevant WHO programmes;
  3. to consider appropriate representation of paediatric experts on the WHO Expert Committee on the Selection and Use of Essential Medicines;
  4. to support Member States in taking appropriate measures through provision of training and strengthening of regulatory capacity according to national and regional circumstances, and in promoting communication and coordination between countries on paediatric clinical trial design, ethical approval and product formulation, including through regulatory networks;
  5. to continue to collaborate with governments, other organizations of the United Nations system, including WTO and WIPO, donor agencies, nongovernmental organizations and the pharmaceutical industry, in order to encourage fair trade in safe and effective medicines for children and adequate financing for securing better access to medicines for children;
  6. to support Member States in implementing, as appropriate, upon request, standards for ethical and appropriate clinical trials of medicines in children, and to facilitate communication and coordination among Member States to promote the sharing of paediatric clinical trial information;
  7. to support analysis and better understanding of the costs of research and development for medicines for children, including for rare diseases in children;
  8. to support countries in implementing relevant policies in line with the 2030 Agenda for Sustainable Development, including Goal 3 and related access to medicine targets, and to provide the necessary technical assistance in this regard, upon request;
  9. to report to the Seventy-first World Health Assembly on progress in the implementation of this resolution.
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 29, 2018